Novo Nordisk reported DKK6.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 5.86 6.53 May/06
FY2025Q4 Dec/2025 6.04 5.89 6.34 Feb/04
FY2025Q3 Sep/2025 4.50 5.52 6.12 Sep/26
FY2025Q2 Jun/2025 5.96 6.00 4.49 Aug/06
FY2025Q1 Mar/2025 6.53 6.35 5.68 May/07




Eps Change Date
Bausch Health Companies USD 1.08 0.08 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Novo Nordisk DKK 1.02 0.1 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025